FARRA, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.289
EU - Europa 5.905
AS - Asia 1.498
AF - Africa 40
SA - Sud America 28
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 15.791
Nazione #
US - Stati Uniti d'America 8.223
PL - Polonia 1.684
IT - Italia 1.088
SE - Svezia 851
DE - Germania 697
CN - Cina 565
UA - Ucraina 441
HK - Hong Kong 289
SG - Singapore 262
TR - Turchia 211
RU - Federazione Russa 188
GB - Regno Unito 187
FI - Finlandia 171
FR - Francia 141
IE - Irlanda 116
BG - Bulgaria 114
BE - Belgio 62
CA - Canada 56
NL - Olanda 33
CH - Svizzera 31
IN - India 29
VN - Vietnam 29
SN - Senegal 26
KR - Corea 24
IR - Iran 23
AU - Australia 19
JP - Giappone 18
ES - Italia 17
BR - Brasile 15
CZ - Repubblica Ceca 12
LU - Lussemburgo 11
TW - Taiwan 11
EU - Europa 10
GR - Grecia 10
CL - Cile 8
MX - Messico 8
MY - Malesia 8
PK - Pakistan 8
DK - Danimarca 7
EG - Egitto 7
HR - Croazia 7
IL - Israele 7
RS - Serbia 7
TH - Thailandia 7
NO - Norvegia 5
PT - Portogallo 5
AT - Austria 4
AR - Argentina 3
MU - Mauritius 3
RO - Romania 3
ZA - Sudafrica 3
AL - Albania 2
CO - Colombia 2
EE - Estonia 2
GG - Guernsey 2
HU - Ungheria 2
IQ - Iraq 2
MD - Moldavia 2
PA - Panama 2
SA - Arabia Saudita 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BF - Burkina Faso 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 15.791
Città #
Warsaw 1.679
Woodbridge 1.039
Ann Arbor 923
Fairfield 914
Chandler 828
Houston 616
Ashburn 587
Jacksonville 432
Trieste 423
Wilmington 423
Seattle 342
Cambridge 291
Hong Kong 273
Princeton 211
Izmir 182
Beijing 169
Singapore 168
Dearborn 164
Sofia 113
Dublin 112
Boardman 84
San Diego 53
Brussels 50
Los Angeles 49
Bremen 38
Helsinki 34
Milan 32
Ottawa 32
Redmond 32
Mestre 31
Kunming 28
Washington 28
Düsseldorf 27
Redwood City 27
Dakar 26
Falls Church 26
Hefei 25
Bern 24
Chicago 24
Santa Clara 24
Nanjing 23
Jinan 21
Phoenix 21
Seoul 21
Shanghai 21
Venezia 21
Duino-Aurisina 20
Des Moines 19
Dong Ket 18
Kocaeli 18
Grafing 17
Napoli 17
Columbus 15
Hebei 15
Dallas 14
Fagagna 14
Padova 14
Guangzhou 13
Nanchang 13
Sacile 13
Atlanta 12
Norwalk 12
Salerno 12
Tianjin 12
Fuzhou 11
Shenyang 11
Udine 11
Fremont 10
Ghent 10
Taipei 10
Buffalo 9
Múggia 9
Sydney 9
Bologna 8
Chengdu 8
San Francisco 8
Toronto 8
Vancouver 8
Zhengzhou 8
Brno 7
Dongguan 7
Hangzhou 7
Indiana 7
London 7
Naples 7
Rome 7
Verona 7
Ho Chi Minh City 6
Montreal 6
Nanning 6
New York 6
Pune 6
Venustiano Carranza 6
Cairo 5
Central 5
Dudenhofen 5
Granada 5
Madrid 5
Martignacco 5
Taizhou 5
Totale 11.244
Nome #
Polysaccharides for the delivery of antitumor drugs 382
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 374
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 370
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules 365
Potential applications of nanocellulose-containing materials in the biomedical field 358
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 336
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 325
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 307
Use of low field NMR for the characterization of gels and biological tissues 302
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 226
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 214
Strategies for delivery of siRNAs to ovarian cancer cells 210
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 209
Mathematical modeling of drug release from natural polysaccharides based matrices 208
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 207
The role of the transcription factor E2F1 in hepatocellular carcinoma 206
null 203
Therapeutic potential and delivery strategies for nucleic acid-based drugs 198
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 194
null 184
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 183
Guar gum/borax hydrogel: rheological, low field NMR and release characterizations 183
Characterization of PLLA scaffolds for biomedical applications 182
Exploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model 180
Use of Low field NMR for the characterisation of gels and biological tissues 179
Drug delivery from polymeric matrices 176
Translation Elongation 175
Ottimizzazione di hydrogel alginato-pluronico per il rilascio di farmaci basati sul DNA 173
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 173
Physical characterization of alginate–Pluronic F127 gel for endoluminal NABDs delivery 172
Thermo-responsive hydrogels from cellulose-based polyelectrolytes and catanionic vesicles for biomedical application 165
Membranes in Drug Delivery 163
null 162
2D DYNAMICAL SIMULATION OF A VIBRATIONAL MILL 160
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 159
Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages 156
Designing of polymeric gels mimicking the normal and fibrotic liver tissues: Effect of viscoelasticity on cells adhesion and survival 156
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 153
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 153
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 153
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 152
null 150
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 149
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 148
null 148
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 147
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 143
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 143
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 138
Improving siRNA Bio-Distribution and Minimizing Side Effects 136
Synthesis and Spontaneous Polymerization of Oligo(ethyleneglycol)-Conjugated Benzofulvene Macromonomers.A Polymer Brush Forming a Physical Hydrogel 134
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 129
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 127
Potential applications of small interferring RNA in the cardiovascular field 126
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 125
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 123
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 122
null 121
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 120
null 119
E2F1 as a molecular drug target in ovarian cancer 116
Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery 115
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 111
null 111
Swelling of viscoelastic matrices by viscoelastic fluids 110
Can rheology be useful in the cystic fibrosis frame 110
Uso di small interfering RNA (SIRNA) per il trattamento di patologie caratterizzate da iperproliferazione cellulare 109
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 109
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 109
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 109
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 108
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system 108
Hydrogels mesh size evaluation 107
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 107
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 106
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 105
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 105
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 104
null 103
SIMPLE, BIOCOMPATIBLE AND COST-EFFECTIVE INULIN BASED siRNA DELIVERY SYSTEMS 102
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 102
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 100
Drug delivery and mathematical modeling: an historical perspective 99
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 99
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 98
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 91
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 90
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 88
Potential Application Of Proteasome Inhibitor Bortezomib For the Treatment Of Hepatocellular Carcinoma 85
Characterisation of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 84
Pluronic gel matrices for stent coating 82
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 82
Mesh Size Distribution Determination of Interpenetrating Polymer Networks Hydrogels 80
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 77
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 76
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 75
ANALYSIS AND MODELLING OF THE DISSOLUTION OF POLYDISPERSED SPHERICAL DRUG PARTICLES 75
null 74
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 74
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 72
Totale 15.301
Categoria #
all - tutte 39.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.874 0 0 166 460 249 427 423 337 283 190 230 109
2020/20211.886 194 128 152 262 159 160 137 151 97 214 69 163
2021/20221.562 40 87 58 207 38 140 111 62 137 129 183 370
2022/20232.489 232 379 247 362 222 358 39 197 258 46 108 41
2023/20241.421 78 84 89 81 166 165 194 262 26 86 106 84
2024/2025279 34 93 152 0 0 0 0 0 0 0 0 0
Totale 16.243